{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:23:09Z","timestamp":1762507389492},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T00:00:00Z","timestamp":1526256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s10147-018-1292-5","type":"journal-article","created":{"date-parts":[[2018,5,14]],"date-time":"2018-05-14T13:21:30Z","timestamp":1526304090000},"page":"951-956","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Intravesical bacillus Calmette\u2013Guerin therapy after second transurethral resection for primary T1 bladder cancer"],"prefix":"10.1007","volume":"23","author":[{"given":"Masato","family":"Baba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susumu","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chul Jang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keita","family":"Takimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Nagasawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Soga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Nagatani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zenkai","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Kawauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,14]]},"reference":[{"key":"1292_CR1","doi-asserted-by":"publisher","first-page":"446","DOI":"10.6004\/jnccn.2013.0059","volume":"11","author":"PE Clark","year":"2013","unstructured":"Clark PE, Agarwal N, Biagioli MC et al (2013) Bladder cancer. J Natl Compr Canc Netw 11:446\u2013475","journal-title":"J Natl Compr Canc Netw"},{"key":"1292_CR2","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk M, Bohle A, Burger M et al (2017) EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur Urol 71:447\u2013461","journal-title":"Eur Urol"},{"key":"1292_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden APM, Oosterlinck W et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49:466\u2013477","journal-title":"Eur Urol"},{"key":"1292_CR4","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.1016\/j.juro.2007.09.003","volume":"178","author":"MC Hall","year":"2007","unstructured":"Hall MC, Chang SS, Dalbagni G et al (2007) Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178:2314\u20132330","journal-title":"J Urol"},{"key":"1292_CR5","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.eururo.2010.03.007","volume":"58","author":"RT Divrik","year":"2010","unstructured":"Divrik RT, Sahin AF, Yildirim U et al (2010) Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recurrence, progression rate, and disease-specific survival: a prospective randomised clinical trial. Eur Urol 58:185\u2013190","journal-title":"Eur Urol"},{"key":"1292_CR6","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1093\/jjco\/hyt016","volume":"43","author":"E Takaoka","year":"2013","unstructured":"Takaoka E, Matsui Y, Inoue T et al (2013) Risk factors for intravesical recurrence in patients with high-grade T1 bladder cancer in the second TUR era. Jpn J Clin Oncol 43:404\u2013409","journal-title":"Jpn J Clin Oncol"},{"key":"1292_CR7","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1111\/j.1464-410X.2006.06144.x","volume":"97","author":"HE Schwaibold","year":"2006","unstructured":"Schwaibold HE, Sivalingam S, May F et al (2006) The value of a second transurethral resection for T1 bladder cancer. BJU Int 97:1199\u20131201","journal-title":"BJU Int"},{"key":"1292_CR8","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1111\/j.1464-410X.2008.07966.x","volume":"102","author":"HW Herr","year":"2008","unstructured":"Herr HW, Donat SM (2008) Quality control in transurethral resection of bladder tumours. BJU Int 102:1242\u20131246","journal-title":"BJU Int"},{"key":"1292_CR9","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1016\/S0022-5347(05)66532-9","volume":"165","author":"A Brauers","year":"2001","unstructured":"Brauers A, Buettner R, Jakse G (2001) Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early? J Urol 165:808\u2013810","journal-title":"J Urol"},{"key":"1292_CR10","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/S0090-4295(01)01522-9","volume":"59","author":"L Schips","year":"2002","unstructured":"Schips L, Augustin H, Zigeuner RE et al (2002) Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer? Urology 59:220\u2013223","journal-title":"Urology"},{"key":"1292_CR11","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1089\/end.2010.0319","volume":"24","author":"MH Ali","year":"2010","unstructured":"Ali MH, Ismail IY, Eltobgy A et al (2010) Evaluation of second-look transurethral resection in restaging of patients with nonmuscle-invasive bladder cancer. J Endourol 24:2047\u20132050","journal-title":"J Endourol"},{"key":"1292_CR12","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1111\/iju.13141","volume":"23","author":"Y Kubota","year":"2016","unstructured":"Kubota Y, Nakaigawa N (2016) Essential content of evidence-based clinical practice guidelines for bladder cancer: the Japanese Urological Association 2015 update. Int J Urol 23:640\u2013645","journal-title":"Int J Urol"},{"key":"1292_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","volume":"169","author":"A B\u00f6hle","year":"2003","unstructured":"B\u00f6hle A, Jocham D, Bock PR (2003) Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol 169:90\u201395","journal-title":"J Urol"},{"key":"1292_CR14","doi-asserted-by":"publisher","first-page":"10","DOI":"10.4103\/0974-7796.163798","volume":"8","author":"K Hashine","year":"2016","unstructured":"Hashine K, Ide T, Nakashima T et al (2016) Results of second transurethral resection for high-grade T1 bladder cancer. Urol Ann 8:10\u201315","journal-title":"Urol Ann"},{"key":"1292_CR15","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1093\/jjco\/hys143","volume":"42","author":"F Kunieda","year":"2012","unstructured":"Kunieda F, Kitamura H, Nishikawa M et al (2012) Watchful waiting versus intravesical BCG therapy for high-grade pT1 bladder cancer with pT0 histology after second transurethral resection: Japan Clinical Oncology Group Study JCOG1019. Jpn J Clin Oncol 42:1094\u20131098","journal-title":"Jpn J Clin Oncol"},{"key":"1292_CR16","doi-asserted-by":"publisher","first-page":"71","DOI":"10.5980\/jpnjurol.106.71","volume":"106","author":"S Tsuzuki","year":"2015","unstructured":"Tsuzuki S, Miki J, Morita J et al (2015) Clinical characteristics of T1 high grade bladder cancer. Jpn J Urol 106:71\u201378","journal-title":"Jpn J Urol"},{"key":"1292_CR17","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.urology.2003.11.049","volume":"63","author":"A B\u00f6hle","year":"2004","unstructured":"B\u00f6hle A, Bock PR (2004) Intravesical bacille Calmette-Gu\u00e9rin versus mitomycin C in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression. Urology 63:682\u2013686","journal-title":"Urology"},{"key":"1292_CR18","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1097\/01.ju.0000181799.81119.fc","volume":"174","author":"HW Herr","year":"2005","unstructured":"Herr HW (2005) Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174:2134\u20132137","journal-title":"J Urol"},{"key":"1292_CR19","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.juro.2013.08.022","volume":"191","author":"JP Sfakianos","year":"2014","unstructured":"Sfakianos JP, Kim PH, Hakimi AA et al (2014) The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Gu\u00e9rin. J Urol 191:341\u2013345","journal-title":"J Urol"},{"key":"1292_CR20","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/j.juro.2010.02.026","volume":"183","author":"A Guevara","year":"2010","unstructured":"Guevara A, Salomon L, Allory Y et al (2010) The role of tumor-free status in repeat resection before intravesical bacillus Calmette-Guerin for high grade Ta, T1 and CIS bladder cancer. J Urol 183:2161\u20132164","journal-title":"J Urol"},{"key":"1292_CR21","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s12894-016-0126-x","volume":"16","author":"K Iida","year":"2016","unstructured":"Iida K, Naiki T, Kawai N et al (2016) Bacillus Calmette-Guerin therapy after the second transurethral resection significantly decreases recurrence in patients with new onset high-grade T1 bladder cancer. BMC Urol 16:8","journal-title":"BMC Urol"},{"key":"1292_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1111\/bju.13102","volume":"116","author":"S Baltac\u0131","year":"2015","unstructured":"Baltac\u0131 S, Bozlu M, Y\u0131ld\u0131r\u0131m A et al (2015) Significance of the interval between first and second transurethral resection on recurrence and progression rates in patients with high-risk non-muscle-invasive bladder cancer treated with maintenance intravesical Bacillus Calmette-Gu\u00e9rin. BJU Int 116:721\u2013726","journal-title":"BJU Int"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-018-1292-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-018-1292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,14]],"date-time":"2019-05-14T04:34:51Z","timestamp":1557808491000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-018-1292-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,14]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1292"],"URL":"https:\/\/doi.org\/10.1007\/s10147-018-1292-5","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,14]]},"assertion":[{"value":"28 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no conflicts of interest in association with the present study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was retrospective observational study. Therefore, informed consent was not obtained from all individual participants included in the study and it was approved by Shiga University of Medical Science Hospital (28-075, 8\/30\/2016, 29-268, 2\/22\/2018) and affiliated hospitals [Kohka Public Hospital (347), Saiseikai Shigaken Hospital (294), Toyosato Hospital (22), Hikone Municipal Hospital (27-7) and Hino Memorial Hospital (30-01)] Institutional Review Board.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}